[Translation] A Phase I Trial of Oral Vascepa (ICOSAPENT ETHYL) Capsules in Chinese Healthy Subjects with Multiple Dosing, Randomized, Open, Parallel Design
评价中国健康受试者连续28天口服Vascepa胶囊后血浆和红细胞EPA的药代动力学(PK)特征及连续28天口服Vascepa胶囊的安全性
[Translation] To evaluate the pharmacokinetic (PK) characteristics of plasma and erythrocyte EPA after 28 consecutive days of oral administration of Vascepa capsules in Chinese healthy subjects and the safety of 28 consecutive days of oral administration of Vascepa capsules